Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity

Toxicology and Applied Pharmacology

Volumn 256, Issue 3, 2011, Pages 300-313

  Raman, Dayanidhi ^b   Milatovic, Snjezana Zaja ^b   Milatovic, Dejan ^b   Splittgerber, Ryan ^b   Fan, Guo Huang ^c   Richmond, Ann ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Amyloid neurotoxicity; Chemokines; Hippocampus; MIP 2; Neuroprotection; SDF 1 CXCL12

Indexed keywords

ADAM PROTEIN; AMYLOID BETA PROTEIN; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; ISOPROSTANE DERIVATIVE; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; P21 ACTIVATED KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN ADAM17; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; GOLGI COMPLEX; HIPPOCAMPUS; MOUSE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PYRAMIDAL NERVE CELL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BRAIN; CHEMOKINE CXCL12; CHEMOKINE CXCL2; CHEMOKINES; F2-ISOPROSTANES; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-8B;

MUS;

EID: 80855148191     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.06.006     Document Type: Article

References (74)

1. Araujo D.M., Cotman C.W. Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 1993, 600:49-55.
2. Asrar S., Meng Y., Zhou Z., Todorovski Z., Huang W.W., Jia Z. Regulation of hippocampal long-term potentiation by p21-activated protein kinase 1 (PAK1). Neuropharmacology 2009, 56:73-80.
3. Bernstein H.G., Stricker R., Lendeckel U., Bertram I., Dobrowolny H., Steiner J., Bogerts B., Reiser G. Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains. Age (Dordr.) 2009, 31:11-25.
4. Bruno V., Copani A., Besong G., Scoto G., Nicoletti F. Neuroprotective activity of chemokines against N-methyl-d-aspartate or beta-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 2000, 399:117-121.
5. Cacalano G., Lee J., Kikly K., Ryan A.M., Pitts-Meek S., Hultgren B., Wood W.I., Moore M.W. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 1994, 265:682-684.
6. Cardona A.E., Sasse M.E., Liu L., Cardona S.M., Mizutani M., Savarin C., Hu T., Ransohoff R.M. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 2008, 112:256-263.
7. Chai X., Forster E., Zhao S., Bock H.H., Frotscher M. Reelin stabilizes the actin cytoskeleton of neuronal processes by inducing n-cofilin phosphorylation at serine3. J. Neurosci. 2009, 29:288-299.
8. Chin J., Massaro C.M., Palop J.J., Thwin M.T., Yu G.Q., Bien-Ly N., Bender A., Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci. 2007, 27:2727-2733.
9. Cook A., Hippensteel R., Shimizu S., Nicolai J., Fatatis A., Meucci O. Interactions between chemokines: regulation of fractalkine/CX3CL1 homeostasis by SDF/CXCL12 in cortical neurons. J. Biol. Chem. 2010, 285:10563-10571.
10. Danik M., Puma C., Quirion R., Williams S. Widely expressed transcripts for chemokine receptor CXCR1 in identified glutamatergic, gamma-aminobutyric acidergic, and cholinergic neurons and astrocytes of the rat brain: a single-cell reverse transcription-multiplex polymerase chain reaction study. J. Neurosci. Res. 2003, 74:286-295.
11. De Felice F.G., Velasco P.T., Lambert M.P., Viola K., Fernandez S.J., Ferreira S.T., Klein W.L. Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 2007, 282:11590-11601.
12. De Felice F.G., Vieira M.N., Bomfim T.R., Decker H., Velasco P.T., Lambert M.P., Viola K.L., Zhao W.Q., Ferreira S.T., Klein W.L. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1971-1976.
13. De Paola M., Buanne P., Biordi L., Bertini R., Ghezzi P., Mennini T. Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures. Neuroimmunomodulation 2007, 14:310-316.
14. Devalaraja R.M., Nanney L.B., Du J., Qian Q., Yu Y., Devalaraja M.N., Richmond A. Delayed wound healing in CXCR2 knockout mice. J. Invest. Dermatol. 2000, 115:234-244.
15. Dugas J.C., Mandemakers W., Rogers M., Ibrahim A., Daneman R., Barres B.A. A novel purification method for CNS projection neurons leads to the identification of brain vascular cells as a source of trophic support for corticospinal motor neurons. J. Neurosci. 2008, 28:8294-8305.
16. Fan X., Patera A.C., Pong-Kennedy A., Deno G., Gonsiorek W., Manfra D.J., Vassileva G., Zeng M., Jackson C., Sullivan L., Sharif-Rodriguez W., Opdenakker G., Van Damme J., Hedrick J.A., Lundell D., Lira S.A., Hipkin R.W. Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. J. Biol. Chem. 2007, 282:11658-11666.
17. Ferretti M.T., Cuello A.C. Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?. Curr. Alzheimer Res. 2011, 8:164-174.
18. Floridi F., Trettel F., Di Bartolomeo S., Ciotti M.T., Limatola C. Signalling pathways involved in the chemotactic activity of CXCL12 in cultured rat cerebellar neurons and CHP100 neuroepithelioma cells. J. Neuroimmunol. 2003, 135:38-46.
19. Futter M., Uematsu K., Bullock S.A., Kim Y., Hemmings H.C., Nishi A., Greengard P., Nairn A.C. Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5). Proc. Natl. Acad. Sci. U.S.A. 2005, 102:3489-3494.
20. Goczalik I., Ulbricht E., Hollborn M., Raap M., Uhlmann S., Weick M., Pannicke T., Wiedemann P., Bringmann A., Reichenbach A., Francke M. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina. Invest. Ophthalmol. Vis. Sci. 2008, 49:4578-4589.
21. Gong Y., Chang L., Viola K.L., Lacor P.N., Lambert M.P., Finch C.E., Krafft G.A., Klein W.L. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:10417-10422.
22. Guyon A., Nahon J.L. Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity. J. Mol. Endocrinol. 2007, 38:365-376.
23. Horuk R., Martin A.W., Wang Z., Schweitzer L., Gerassimides A., Guo H., Lu Z., Hesselgesser J., Perez H.D., Kim J., Parker J., Hadley T.J., Peiper S.C. Expression of chemokine receptors by subsets of neurons in the central nervous system. J. Immunol. 1997, 158:2882-2890.
24. Hosking M.P., Liu L., Ransohoff R.M., Lane T.E. A protective role for ELR+chemokines during acute viral encephalomyelitis. PLoS Pathog. 2009, 5:e1000648.
25. Hosking M.P., Tirotta E., Ransohoff R.M., Lane T.E. CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PLoS One 2010, 5:e11340.
26. Ito S., Sawada M., Haneda M., Ishida Y., Isobe K. Amyloid-beta peptides induce several chemokine mRNA expressions in the primary microglia and Ra2 cell line via the PI3K/Akt and/or ERK pathway. Neurosci. Res. 2006, 56:294-299.
27. Khan M.Z., Brandimarti R., Shimizu S., Nicolai J., Crowe E., Meucci O. The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ. 2008, 15:1663-1672.
28. Laing J.M., Smith C.C., Aurelian L. Multi-targeted neuroprotection by the HSV-2 gene ICP10PK includes robust bystander activity through PI3-K/Akt and/or MEK/ERK-dependent neuronal release of vascular endothelial growth factor and fractalkine. J. Neurochem. 2010, 112:662-676.
29. Laske C., Stellos K., Eschweiler G.W., Leyhe T., Gawaz M. Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: a contribution to a deficient hematopoietic brain support?. J. Alzheimers Dis. 2008, 15:83-95.
30. Lauren H.B., Lopez-Picon F.R., Brandt A.M., Rios-Rojas C.J., Holopainen I.E. Transcriptome analysis of the hippocampal CA1 pyramidal cell region after kainic acid-induced status epilepticus in juvenile rats. PLoS One 2010, 5:e10733.
31. Lavi E., Strizki J.M., Ulrich A.M., Zhang W., Fu L., Wang Q., O'Connor M., Hoxie J.A., Gonzalez-Scarano F. CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol. 1997, 151:1035-1042.
32. Limatola C., Ciotti M.T., Mercanti D., Santoni A., Eusebi F. Signaling pathways activated by chemokine receptor CXCR2 and AMPA-type glutamate receptors and involvement in granule cells survival. J. Neuroimmunol. 2002, 123:9-17.
33. Lin W.H., Nebhan C.A., Anderson B.R., Webb D.J. Vasodilator-stimulated phosphoprotein (VASP) induces actin assembly in dendritic spines to promote their development and potentiate synaptic strength. J. Biol. Chem. 2010, 285:36010-36020.
34. Liu L., Darnall L., Hu T., Choi K., Lane T.E., Ransohoff R.M. Myelin repair is accelerated by inactivating CXCR2 on nonhematopoietic cells. J. Neurosci. 2010, 30:9074-9083.
35. Lu D.Y., Tang C.H., Yeh W.L., Wong K.L., Lin C.P., Chen Y.H., Lai C.H., Chen Y.F., Leung Y.M., Fu W.M. SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur. J. Pharmacol. 2009, 613:146-154.
36. Luo Y., Fischer F.R., Hancock W.W., Dorf M.E. Macrophage inflammatory protein-2 and KC induce chemokine production by mouse astrocytes. J. Immunol. 2000, 165:4015-4023.
37. Ma Q.L., Yang F., Calon F., Ubeda O.J., Hansen J.E., Weisbart R.H., Beech W., Frautschy S.A., Cole G.M. p21-activated kinase-aberrant activation and translocation in Alzheimer disease pathogenesis. J. Biol. Chem. 2008, 283:14132-14143.
38. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14500-14505.
39. Meucci O., Fatatis A., Simen A.A., Miller R.J. Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8075-8080.
40. Milatovic D., Aschner M. Measurement of isoprostanes as markers of oxidative stress in neuronal tissue. Curr Protoc Toxicol 2009, Chapter 12, Unit12 14.
41. Milatovic D., Zaja-Milatovic S., Montine K.S., Horner P.J., Montine T.J. Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum. J. Neurochem. 2003, 87:1518-1526.
42. Milatovic D., Montine T.J., Zaja-Milatovic S., Madison J.L., Bowman A.B., Aschner M. Morphometric analysis in neurodegenerative disorders. Curr. Protoc. Toxicol. 2010, 12:1-14.
43. Miller R.J., Rostene W., Apartis E., Banisadr G., Biber K., Milligan E.D., White F.A., Zhang J. Chemokine action in the nervous system. J. Neurosci. 2008, 28:11792-11795.
44. Montine T.J., Milatovic D., Gupta R.C., Valyi-Nagy T., Morrow J.D., Breyer R.M. Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J. Neurochem. 2002, 83:463-470.
45. Morrow J.D., Hill K.E., Burk R.F., Nammour T.M., Badr K.F., Roberts L.J. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:9383-9387.
46. Neel N.F., Barzik M., Raman D., Sobolik-Delmaire T., Sai J., Ham A.J., Mernaugh R.L., Gertler F.B., Richmond A. VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. J. Cell Sci. 2009, 122:1882-1894.
47. Nguyen D., Stangel M. Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Brain Res. Dev. Brain Res. 2001, 128:77-81.
48. Nguyen T.V., Galvan V., Huang W., Banwait S., Tang H., Zhang J., Bredesen D.E. Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664. J. Neurochem. 2008, 104:1065-1080.
49. Nikolic M. The Pak1 kinase: an important regulator of neuronal morphology and function in the developing forebrain. Mol. Neurobiol. 2008, 37:187-202.
50. Odemis V., Boosmann K., Heinen A., Kury P., Engele J. CXCR7 is an active component of SDF-1 signalling in astrocytes and Schwann cells. J. Cell Sci. 2010, 123:1081-1088.
51. Parachikova A., Cotman C.W. Reduced CXCL12/CXCR4 results in impaired learning and is downregulated in a mouse model of Alzheimer disease. Neurobiol. Dis. 2007, 28:143-153.
52. Pratico D. The neurobiology of isoprostanes and Alzheimer's disease. Biochim. Biophys. Acta 2010, 1801:930-933.
53. Pratico D., Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J. Alzheimers Dis. 2004, 6:171-175.
54. Pratico D., V M.Y.L., Trojanowski J.Q., Rokach J., Fitzgerald G.A. Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. Faseb J 1998, 12:1777-1783.
55. Puma C., Danik M., Quirion R., Ramon F., Williams S. The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 2001, 78:960-971.
56. Re D.B., Przedborski S. Fractalkine: moving from chemotaxis to neuroprotection. Nat. Neurosci. 2006, 9:859-861.
57. Rondeau V., Jacqmin-Gadda H., Commenges D., Helmer C., Dartigues J.F. Aluminum and silica in drinking water and the risk of Alzheimer's disease or cognitive decline: findings from 15-year follow-up of the PAQUID cohort. Am. J. Epidemiol. 2009, 169:489-496.
58. Sai J., Raman D., Liu Y., Wikswo J., Richmond A. Parallel phosphatidylinositol 3-kinase (PI3K)-dependent and Src-dependent pathways lead to CXCL8-mediated Rac2 activation and chemotaxis. J. Biol. Chem. 2008, 283:26538-26547.
59. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
60. Sengupta R., Burbassi S., Shimizu S., Cappello S., Vallee R.B., Rubin J.B., Meucci O. Morphine increases brain levels of ferritin heavy chain leading to inhibition of CXCR4-mediated survival signaling in neurons. J. Neurosci. 2009, 29:2534-2544.
61. Shcherbatykh I., Carpenter D.O. The role of metals in the etiology of Alzheimer's disease. J. Alzheimers Dis. 2007, 11:191-205.
62. Shyu W.C., Lin S.Z., Yen P.S., Su C.Y., Chen D.C., Wang H.J., Li H. Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. J. Pharmacol. Exp. Ther. 2008, 324:834-849.
63. Volinsky N., Gantman A., Yablonski D. A Pak- and Pix-dependent branch of the SDF-1alpha signalling pathway mediates T cell chemotaxis across restrictive barriers. Biochem. J. 2006, 397:213-222.
64. Wang J.Y., Shum A.Y., Chao C.C., Kuo J.S., Wang J.Y. Production of macrophage inflammatory protein-2 following hypoxia/reoxygenation in glial cells. Glia 2000, 32:155-164.
65. Wang D., Sai J., Carter G., Sachpatzidis A., Lolis E., Richmond A. PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry 2002, 41:7100-7107.
66. Wang Y., Luo W., Stricker R., Reiser G. Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. J. Neurochem. 2006, 98:1046-1060.
67. Wang Y., Luo W., Reiser G. Activation of protease-activated receptors in astrocytes evokes a novel neuroprotective pathway through release of chemokines of the growth-regulated oncogene/cytokine-induced neutrophil chemoattractant family. Eur. J. Neurosci. 2007, 26:3159-3168.
68. Wang Y., Yang F., Fu Y., Huang X., Wang W., Jiang X., Gritsenko M.A., Zhao R., Monore M.E., Pertz O.C., Purvine S.O., Orton D.J., Jacobs J.M., Camp D.G., Smith R.D., Klemke R.L. Spatial phosphoprotein profiling reveals a compartmentalized extracellular signal-regulated kinase switch governing neurite growth and retraction. J. Biol. Chem. 2011, 286:18190-18201.
69. Watson K., Fan G.H. Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol. Pharmacol. 2005, 67:757-765.
70. Wu Y., Peng H., Cui M., Whitney N.P., Huang Y., Zheng J.C. CXCL12 increases human neural progenitor cell proliferation through Akt-1/FOXO3a signaling pathway. J. Neurochem. 2009, 109:1157-1167.
71. Xia M.Q., Hyman B.T. Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 1999, 5:32-41.
72. Zhang H., Webb D.J., Asmussen H., Niu S., Horwitz A.F. A GIT1/PIX/Rac/PAK signaling module regulates spine morphogenesis and synapse formation through MLC. J. Neurosci. 2005, 25:3379-3388.
73. Zhao L., Ma Q.L., Calon F., Harris-White M.E., Yang F., Lim G.P., Morihara T., Ubeda O.J., Ambegaokar S., Hansen J.E., Weisbart R.H., Teter B., Frautschy S.A., Cole G.M. Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 2006, 9:234-242.
74. Zhu Y., Yang G.Y., Ahlemeyer B., Pang L., Che X.M., Culmsee C., Klumpp S., Krieglstein J. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J. Neurosci. 2002, 22:3898-3909.